SEC Form 4 · accession 0001144204-15-042748
Cytosorbents Corp · CTSO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael G. Bator
Director
Period of report
Jul 14, 2015
Accepted (ET)
Jul 15, 2015 · 6:27 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001175151
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionF1 | $6.65 | Jul 14, 2015 | A | 6,000 | A | — | Jul 14, 2025 | Common Stock | 6,000 | 6,000 | D |
Explanation of responses
- F1The options vest as to 25% of the shares on each quarterly anniversary of the grant date.